BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
1821 – 1830 of 3090
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Antibodies reactive to cleaved sites in complement proteins enable highly specific measurement of soluble markers of complement activation.
(
- Contribution to journal › Article
-
Mark
Anthropometric Measures at Multiple Times Throughout Life and Prostate Cancer Diagnosis, Metastasis, and Death.
(
- Contribution to journal › Article
-
Mark
Recurrent PRDM10 Gene Fusions in Undifferentiated Pleomorphic Sarcoma.
(
- Contribution to journal › Article
-
Mark
Central nervous system relapse in peripheral T-cell lymphomas: A Swedish lymphoma registry study.
(
- Contribution to journal › Article
-
Mark
Therapeutic Targeting of Nuclear Gamma-Tubulin in RB1-negative Tumors.
(
- Contribution to journal › Article
-
Mark
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
(
- Contribution to journal › Article
-
Mark
Serum markers in prostate cancer detection.
(
- Contribution to journal › Article
-
Mark
Clinical and molecular complexity of breast cancer metastases.
(
- Contribution to journal › Scientific review
-
Mark
Age influences the clinical significance of atypical glandular cells on cytology.
(
- Contribution to journal › Article
-
Mark
Glioblastomas, astrocytomas and oligodendrogliomas linked to Lynch syndrome.
(
- Contribution to journal › Article